Author

S. Sherwood

Observed names: S Sherwood, Sabrina J. Sherwood

Institution: Eli Lilly (United States)

Observed institutions: Eli Lilly (United States), St. Luke's Cystic Fibrosis Center of Idaho

ORCID: 0009-0002-7753-5890

Observed ORCID: 0009-0002-7753-5890

OpenAlex ID: A5074292949

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

2021 · N. Harbeck, P. Rastogi, et al. · Annals of Oncology · 381

48P Abemaciclib combined with adjuvant endocrine therapy in patients from Asia with high risk early breast cancer: monarchE

2021 · Y-S. Yap, S-B. Kim, et al. · Annals of Oncology · 5

1423TiP CYCLONE 3: A phase III, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer (mHSPC)

2022 · R.R. McKay, N. Agarwal, et al. · Annals of Oncology · 2

201P Abemaciclib (abema) combined with adjuvant endocrine therapy (ET) in patients from monarchE in Asia with high-risk early breast cancer (EBC)

2025 · M. Toi, S-B. Kim, et al. · ESMO Open · 1

LBA 1 Baseline characteristics of patients from Asia enrolled in monarchE, evaluating abemaciclib in high risk early breast cancer

2020 · Z. Jiang, T. Nakayama, et al. · Annals of Oncology · 1

A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis

2024 · Sabrina J. Sherwood, Casey Tak, et al. · Pediatric Pulmonology

Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib plus adjuvant endocrine therapy for high-risk early breast cancer

2021 · M Reinisch, J O’Shaughnessy, et al. · Senologie - Zeitschrift für Mammadiagnostik und -therapie

Works count: 7

Citation count: 390

H-index: 2

I10-index: 1